{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T13:07:56Z","timestamp":1789477676993,"version":"build-2803163510"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12551-x","type":"journal-article","created":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T12:59:03Z","timestamp":1789477143000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Unravelling the role of the non-coding RNAs PVT1\/miR-181a in orchestrating IL-23\/ROR\u03b3t and FOXP3\/IL-10 axes in thrombocytopenia associated with systemic lupus erythematosus: insights into the clinical paradox of antiphospholipid syndrome"],"prefix":"10.1007","volume":"53","author":[{"given":"Mai A.","family":"Abd-Elmawla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olfat G.","family":"Shaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwa","family":"Mamdouh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samer S.","family":"Zekry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaymaa G.","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gehan A.","family":"Hegazy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghada","family":"Ayeldeen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,15]]},"reference":[{"issue":"17","key":"12551_CR1","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1001\/jama.2024.2315","volume":"331","author":"CH Siegel","year":"2024","unstructured":"Siegel CH, Sammaritano LR (2024) Systemic lupus erythematosus: a review. JAMA 331(17):1480\u20131491","journal-title":"JAMA"},{"issue":"9","key":"12551_CR2","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/s41584-021-00668-1","volume":"17","author":"MR Barber","year":"2021","unstructured":"Barber MR et al (2021) Global epidemiology of systemic lupus erythematosus. Nat Rev Rheumatol 17(9):515\u2013532","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"12551_CR3","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1136\/ard-2023-224762","volume":"83","author":"A Fanouriakis","year":"2024","unstructured":"Fanouriakis A et al (2024) EULAR recommendations for the management of systemic lupus erythematosus: 2023 update. Ann Rheum Dis 83(1):15\u201329","journal-title":"Ann Rheum Dis"},{"key":"12551_CR4","doi-asserted-by":"crossref","unstructured":"Santacruz JC et al (2022) A practical perspective of the hematologic manifestations of systemic lupus erythematosus. Cureus 14(3)","DOI":"10.7759\/cureus.22938"},{"key":"12551_CR5","doi-asserted-by":"publisher","first-page":"102887","DOI":"10.1016\/j.jaut.2022.102887","volume":"132","author":"Y Jiang","year":"2022","unstructured":"Jiang Y et al (2022) Systemic lupus erythematosus-complicating immune thrombocytopenia: from pathogenesis to treatment. J Autoimmun 132:102887","journal-title":"J Autoimmun"},{"issue":"4","key":"12551_CR6","doi-asserted-by":"publisher","first-page":"103297","DOI":"10.1016\/j.autrev.2023.103297","volume":"22","author":"ON Pamuk","year":"2023","unstructured":"Pamuk ON, Ali SM, Hasni S (2023) Development of systemic lupus erythematosus in patients with immune thrombocytopenic purpura: A systematic meta-analysis. Autoimmun rev 22(4):103297","journal-title":"Autoimmun rev"},{"issue":"4","key":"12551_CR7","doi-asserted-by":"publisher","first-page":"159","DOI":"10.5152\/eurjrheum.2023.23069","volume":"10","author":"ON Pamuk","year":"2023","unstructured":"Pamuk ON (2023) Thrombocytopenia in patients with systemic lupus erythematosus. Eur J Rheumatol 10(4):159","journal-title":"Eur J Rheumatol"},{"key":"12551_CR8","doi-asserted-by":"publisher","first-page":"1525469","DOI":"10.3389\/fimmu.2024.1525469","volume":"15","author":"Y Zhu","year":"2025","unstructured":"Zhu Y et al (2025) Inhibition SIRT1 to regulate FOXP3 or ROR\u03b3t can restore the balance of Treg\/Th17 axis in ulcerative colitis and enhance the anti-inflammatory effect of moxibustion. Front Immunol 15:1525469","journal-title":"Front Immunol"},{"issue":"3","key":"12551_CR9","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s12026-022-09355-z","volume":"71","author":"BA Ozgur","year":"2023","unstructured":"Ozgur BA et al (2023) The role of cytokines and T-bet, GATA3, ROR-\u03b3t, and FOXP3 transcription factors of T cell subsets in the natural clinical progression of Type 1 Diabetes. Immunol Res 71(3):451\u2013462","journal-title":"Immunol Res"},{"issue":"2","key":"12551_CR10","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1093\/cei\/uxab007","volume":"207","author":"K Furuyama","year":"2022","unstructured":"Furuyama K et al (2022) ROR\u03b3t+ Foxp3\u2009+\u2009regulatory T cells in the regulation of autoimmune arthritis. Clin Exp Immunol 207(2):176\u2013187","journal-title":"Clin Exp Immunol"},{"issue":"4","key":"12551_CR11","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.51248\/.v43i4.3107","volume":"43","author":"RMK Al-Jumaily","year":"2023","unstructured":"Al-Jumaily RMK et al (2023) Gene expression of Interleukin-10 and Foxp3 as critical biomarkers in rheumatoid arthritis patients. Biomedicine 43(4):1183\u20131187","journal-title":"Biomedicine"},{"issue":"2","key":"12551_CR12","doi-asserted-by":"publisher","first-page":"103389","DOI":"10.1016\/j.retram.2023.103389","volume":"71","author":"M Kargar","year":"2023","unstructured":"Kargar M et al (2023) Regulatory factors involved in Th17\/Treg cell balance of immune thrombocytopenia. Curr Res Translational Med 71(2):103389","journal-title":"Curr Res Translational Med"},{"key":"12551_CR13","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.thromres.2022.02.021","volume":"213","author":"G Zhang","year":"2022","unstructured":"Zhang G et al (2022) HMGB1 is increased in patients with immune thrombocytopenia and negatively associates with Tregs. Thromb Res 213:128\u2013136","journal-title":"Thromb Res"},{"key":"12551_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13223-021-00620-8","volume":"17","author":"Y Guan","year":"2021","unstructured":"Guan Y et al (2021) MiRNA-221-5p suppressed the Th17\/Treg ratio in asthma via ROR\u03b3t\/Foxp3 by targeting SOCS1. Allergy Asthma Clin Immunol 17:1\u201314","journal-title":"Allergy Asthma Clin Immunol"},{"key":"12551_CR15","doi-asserted-by":"publisher","first-page":"120965","DOI":"10.1016\/j.lfs.2022.120965","volume":"309","author":"NA Mehana","year":"2022","unstructured":"Mehana NA et al (2022) LncRNA MEG3 regulates the interplay between Th17 and Treg cells in Beh\u00e7et\u2019s disease and systemic lupus erythematosus. Life Sci 309:120965","journal-title":"Life Sci"},{"issue":"8","key":"12551_CR16","doi-asserted-by":"publisher","first-page":"11609","DOI":"10.1007\/s00210-026-05061-x","volume":"399","author":"NM Aborehab","year":"2026","unstructured":"Aborehab NM et al (2026) Malathion-induced neurological alterations associated with dysregulation of ROR\u03b3t\/STAT3\/IL-17 and FOXP3\/STAT5\/IL-10 pathways: potential neuroprotective effects of BCG. Naunyn Schmiedebergs Arch Pharmacol 399(8):11609\u201311627","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"12551_CR17","doi-asserted-by":"crossref","unstructured":"Timasheva Y et al (2023) The role of the long non-coding RNA gene PVT1 polymorphism in the development of multiple sclerosis. Biomics 2023:54\u201359","DOI":"10.31301\/2221-6197.bmcs.2023-8"},{"issue":"5","key":"12551_CR18","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.17305\/bb.2024.10237","volume":"24","author":"Y-n Li","year":"2024","unstructured":"Li Y-n et al (2024) The relationship of peripheral blood lncRNA-PVT1 and miR-146a levels with Th17\/Treg cytokines in patients with Hashimoto\u2019s thyroiditis and their clinical significance. Biomolecules Biomed 24(5):1170","journal-title":"Biomolecules Biomed"},{"issue":"1","key":"12551_CR19","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1080\/16078454.2021.1974200","volume":"26","author":"L Yu","year":"2021","unstructured":"Yu L et al (2021) Decreasing lncRNA PVT1 causes Treg\/Th17 imbalance via NOTCH signaling in immune thrombocytopenia. Hematology 26(1):734\u2013740","journal-title":"Hematology"},{"issue":"1","key":"12551_CR20","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/ncb3453","volume":"19","author":"KM Tsanov","year":"2017","unstructured":"Tsanov KM et al (2017) LIN28 phosphorylation by MAPK\/ERK couples signalling to the post-transcriptional control of pluripotency. Nat Cell Biol 19(1):60\u201367","journal-title":"Nat Cell Biol"},{"issue":"5","key":"12551_CR21","doi-asserted-by":"publisher","first-page":"e3326","DOI":"10.1002\/jgm.3326","volume":"23","author":"RS Abdul-Maksoud","year":"2021","unstructured":"Abdul-Maksoud RS et al (2021) Circulating miR\u2010181a and miR\u2010223 expression with the potential value of biomarkers for the diagnosis of systemic lupus erythematosus and predicting lupus nephritis. J Gene Med 23(5):e3326","journal-title":"J Gene Med"},{"key":"12551_CR22","doi-asserted-by":"crossref","unstructured":"Chen S et al (2022) MYC-mediated silencing of miR-181a-5p promotes pathogenic Th17 responses by modulating AKT3-FOXO3 signaling. Iscience 25(10)","DOI":"10.1016\/j.isci.2022.105176"},{"issue":"5","key":"12551_CR23","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1177\/09612033241238053","volume":"33","author":"JP Casta\u00f1eda-Gonz\u00e1lez","year":"2024","unstructured":"Casta\u00f1eda-Gonz\u00e1lez JP et al (2024) Comparison of the SLE Risk Probability Index (SLERPI) scale against the European League Against Rheumatism\/American College of Rheumatology (ACR\/EULAR) and Systemic Lupus International Collaborating Clinics (SLICC) criteria. Lupus 33(5):520\u2013524","journal-title":"Lupus"},{"issue":"10","key":"12551_CR24","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1002\/art.42624","volume":"75","author":"M Barbhaiya","year":"2023","unstructured":"Barbhaiya M et al (2023) The 2023 ACR\/EULAR antiphospholipid syndrome classification criteria. Arthritis Rheumatol 75(10):1687\u20131702","journal-title":"Arthritis Rheumatol"},{"issue":"12","key":"12551_CR25","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1177\/09612033231206451","volume":"32","author":"MC Nelson","year":"2023","unstructured":"Nelson MC et al (2023) A single-center model for implementation of SLEDAI documentation adherence in childhood-onset systemic lupus erythematosus (cSLE). Lupus 32(12):1447\u20131452","journal-title":"Lupus"},{"key":"12551_CR26","doi-asserted-by":"publisher","first-page":"1093213","DOI":"10.3389\/fmed.2022.1093213","volume":"9","author":"B Lerkvaleekul","year":"2022","unstructured":"Lerkvaleekul B et al (2022) Evaluating performance of the 2019 EULAR\/ACR, 2012 SLICC, and 1997 ACR criteria for classifying adult-onset and childhood-onset systemic lupus erythematosus: a systematic review and meta-analysis. Front Med 9:1093213","journal-title":"Front Med"},{"key":"12551_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cca.2017.08.038","volume":"474","author":"D Lu","year":"2017","unstructured":"Lu D et al (2017) lncRNA PVT1 in cancer: a review and meta-analysis. Clin Chim Acta 474:1\u20137","journal-title":"Clin Chim Acta"},{"issue":"1","key":"12551_CR28","doi-asserted-by":"publisher","first-page":"2157382","DOI":"10.1080\/09537104.2022.2157382","volume":"34","author":"W Li","year":"2023","unstructured":"Li W, Lv Y, Sun Y (2023) Roles of non-coding RNA in megakaryocytopoiesis and thrombopoiesis: new target therapies in ITP. Platelets 34(1):2157382","journal-title":"Platelets"},{"issue":"10","key":"12551_CR29","doi-asserted-by":"publisher","first-page":"3125","DOI":"10.3324\/haematol.2023.284951","volume":"109","author":"B Xu","year":"2024","unstructured":"Xu B et al (2024) Epigenetic regulation of megakaryopoiesis and platelet formation. Haematologica 109(10):3125","journal-title":"Haematologica"},{"issue":"3","key":"12551_CR30","first-page":"240","volume":"9","author":"N Dahiya","year":"2020","unstructured":"Dahiya N, Atreya CD (2020) MiR-181a reduces platelet activation via the inhibition of endogenous RAP1B. Microrna 9(3):240\u2013246","journal-title":"Microrna"},{"issue":"3","key":"12551_CR31","doi-asserted-by":"publisher","first-page":"e59532","DOI":"10.1371\/journal.pone.0059532","volume":"8","author":"S Lin","year":"2013","unstructured":"Lin S et al (2013) Prognostic role of microRNA-181a\/b in hematological malignancies: a meta-analysis. PLoS ONE 8(3):e59532","journal-title":"PLoS ONE"},{"key":"12551_CR32","doi-asserted-by":"publisher","first-page":"107602962210935","DOI":"10.1177\/10760296221093595","volume":"28","author":"Y Zhao","year":"2022","unstructured":"Zhao Y et al (2022) The extensive regulation of microRNA in immune thrombocytopenia. Clin Appl Thromb Hemost 28:10760296221093595","journal-title":"Clin Appl Thromb Hemost"},{"issue":"4","key":"12551_CR33","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1007\/s11239-021-02467-7","volume":"52","author":"M Norouzi","year":"2021","unstructured":"Norouzi M, Mesbah-Namin SA, Deyhim MR (2021) Analysis of changes in the expression pattern of miR-326 and miR-145 during storage of platelet concentrate in blood bank condition and its relationship with some markers of platelet quality. J Thromb Thrombolysis 52(4):1036\u20131042","journal-title":"J Thromb Thrombolysis"},{"issue":"4","key":"12551_CR34","doi-asserted-by":"publisher","first-page":"e0122784","DOI":"10.1371\/journal.pone.0122784","volume":"10","author":"S Yu","year":"2015","unstructured":"Yu S et al (2015) miR-326 targets antiapoptotic Bcl-xL and mediates apoptosis in human platelets. PLoS ONE 10(4):e0122784","journal-title":"PLoS ONE"},{"issue":"7","key":"12551_CR35","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1038\/ncb1741","volume":"10","author":"C Labbaye","year":"2008","unstructured":"Labbaye C et al (2008) A three-step pathway comprising PLZF\/miR-146a\/CXCR4 controls megakaryopoiesis. Nat Cell Biol 10(7):788\u2013801","journal-title":"Nat Cell Biol"},{"key":"12551_CR36","doi-asserted-by":"crossref","unstructured":"El-Shazly AAA et al (2026) Unraveling miRNA-mediated TGF-\u03b2\/hedgehog Signaling in bleomycin-induced pulmonary fibrosis: targeting inflammation\u2013fibrosis crosstalk with candesartan and chlorogenic acid. Bioorganic Chemistry 173:109655","DOI":"10.1016\/j.bioorg.2026.109655"},{"issue":"3","key":"12551_CR37","doi-asserted-by":"publisher","first-page":"e70756","DOI":"10.1002\/jbt.70756","volume":"40","author":"AS Doghish","year":"2026","unstructured":"Doghish AS et al (2026) Unraveling the Function of lncRNAs in Gliomas: Interaction With Signaling Pathways and Therapeutic Opportunities. J Biochem Mol Toxicol 40(3):e70756","journal-title":"J Biochem Mol Toxicol"},{"issue":"4","key":"12551_CR38","doi-asserted-by":"publisher","first-page":"e70102","DOI":"10.1002\/iub.70102","volume":"78","author":"HIA El-Moaty","year":"2026","unstructured":"El-Moaty HIA et al (2026) Deciphering the Angiogenic Switch: The Role of miRNAs in Breast Cancer. IUBMB Life 78(4):e70102","journal-title":"IUBMB Life"},{"issue":"3","key":"12551_CR39","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1139\/cjpp-2020-0268","volume":"99","author":"Y Cheng","year":"2021","unstructured":"Cheng Y, Hu Q, Zhou J (2021) Silencing of lncRNA PVT1 ameliorates streptozotocin-induced pancreatic \u03b2 cell injury and enhances insulin secretory capacity by regulating miR-181a-5p. Can J Physiol Pharmacol 99(3):303\u2013312","journal-title":"Can J Physiol Pharmacol"},{"key":"12551_CR40","doi-asserted-by":"crossref","unstructured":"Abdelmawla MA et al (2026) Circadian rhythms and non-coding RNAs: mechanistic insights, clinical impact, and future opportunities for personalized medicine. Cancer Cell Int 26 (233)","DOI":"10.1186\/s12935-026-04369-1"},{"key":"12551_CR41","doi-asserted-by":"crossref","unstructured":"Ayeldeen G et al (2026) The coordinated regulation of CASC2\/miR-200c\/miR-20b and SIRT1\/ACE-2\/IL-6 Axes in COVID-19 pneumonia: Novel molecular diagnostic and therapeutic insights. Arch Biochem Biophys 782:110877","DOI":"10.1016\/j.abb.2026.110877"},{"issue":"1","key":"12551_CR42","doi-asserted-by":"publisher","first-page":"24","DOI":"10.2174\/2589977513666210707114520","volume":"14","author":"A Sharma","year":"2022","unstructured":"Sharma A et al (2022) IL-23\/Th17 axis: a potential therapeutic target of psoriasis. Curr Drug Res Reviews Formerly: Curr Drug Abuse Reviews 14(1):24\u201336","journal-title":"Curr Drug Res Reviews Formerly: Curr Drug Abuse Reviews"},{"issue":"2","key":"12551_CR43","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1093\/intimm\/dxae049","volume":"37","author":"KN Weinstein","year":"2025","unstructured":"Weinstein KN, Domeier PP, Ziegler SF (2025) A splice of life: the discovery, function, and clinical implications of FOXP3 isoforms in autoimmune disease. Int Immunol 37(2):83\u201390","journal-title":"Int Immunol"},{"issue":"2","key":"12551_CR44","first-page":"1","volume":"21","author":"D Sayed","year":"2014","unstructured":"Sayed D et al (2014) Is Foxp3 a good marker for regulatory T cells. Egypt J Immunol 21(2):1\u20138","journal-title":"Egypt J Immunol"},{"issue":"1","key":"12551_CR45","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12979-021-00240-1","volume":"18","author":"C Kim","year":"2021","unstructured":"Kim C et al (2021) miR-181a-regulated pathways in T-cell differentiation and aging. Immun Ageing 18(1):28","journal-title":"Immun Ageing"},{"key":"12551_CR46","doi-asserted-by":"publisher","first-page":"758","DOI":"10.3389\/fimmu.2017.00758","volume":"8","author":"S Ghorbani","year":"2017","unstructured":"Ghorbani S et al (2017) MicroRNA-181 variants regulate T cell phenotype in the context of autoimmune neuroinflammation. Front Immunol 8:758","journal-title":"Front Immunol"},{"key":"12551_CR47","doi-asserted-by":"publisher","first-page":"107088","DOI":"10.1016\/j.phrs.2024.107088","volume":"201","author":"C Shi","year":"2024","unstructured":"Shi C et al (2024) Lipocalin 2 (LCN2) confers acquired resistance to almonertinib in NSCLC through LCN2-MMP-9 signaling pathway. Pharmacol Res 201:107088","journal-title":"Pharmacol Res"},{"issue":"1","key":"12551_CR48","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1186\/s12882-021-02396-w","volume":"22","author":"H Yang","year":"2021","unstructured":"Yang H et al (2021) Up-regulation of matrix metalloproteinases-9 in the kidneys of diabetic rats and the association with neutrophil gelatinase-associated lipocalin. BMC Nephrol 22(1):211","journal-title":"BMC Nephrol"},{"issue":"4","key":"12551_CR49","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1007\/s11739-023-03292-x","volume":"18","author":"A Lipari","year":"2023","unstructured":"Lipari A et al (2023) Bleeding and thrombotic events in a patient with lupus anticoagulant-associated hypoprothrombinemia and antiphospholipid antibody syndromes: managing hemostasis between Scylla and Charybdis. Intern Emerg Med 18(4):1233\u20131238","journal-title":"Intern Emerg Med"},{"issue":"11","key":"12551_CR50","doi-asserted-by":"publisher","first-page":"103447","DOI":"10.1016\/j.autrev.2023.103447","volume":"22","author":"D Menichelli","year":"2023","unstructured":"Menichelli D et al (2023) Risk of venous thromboembolism in autoimmune diseases: a comprehensive review. Autoimmun rev 22(11):103447","journal-title":"Autoimmun rev"},{"key":"12551_CR51","doi-asserted-by":"crossref","unstructured":"Gaspar P et al (2025) Risk factors for bleeding in patients with thrombotic antiphospholipid syndrome during antithrombotic therapy. Lupus 34 (4):405\u2013411","DOI":"10.1177\/09612033251322927"},{"issue":"5","key":"12551_CR52","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1097\/MBC.0000000000001083","volume":"34","author":"MC Fuentes-Lacouture","year":"2023","unstructured":"Fuentes-Lacouture MC et al (2023) Why do patients with antiphospholipid syndrome bleed? A clinical paradox. Blood Coagul Fibrinolysis 34(5):257\u2013262","journal-title":"Blood Coagul Fibrinolysis"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12551-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12551-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12551-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T12:59:08Z","timestamp":1789477148000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-12551-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,15]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12551"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12551-x","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,15]]},"assertion":[{"value":"26 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Blood samples were collected with full informed consent from all included subjects. All study protocols were approved by the Research Ethics Committee for experimental and clinical studies at the Faculty of Pharmacy of Cairo University (REC-FOPCU).","order":2,"name":"Ethics","label":"Ethical approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1576"}}